Details for New Drug Application (NDA): 218783
✉ Email this page to a colleague
NDA 218783 describes DICHLORPHENAMIDE, which is a drug marketed by Rising and is included in one NDA. It is available from one supplier. Additional details are available on the DICHLORPHENAMIDE profile page.
The generic ingredient in DICHLORPHENAMIDE is dichlorphenamide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
The generic ingredient in DICHLORPHENAMIDE is dichlorphenamide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
Summary for 218783
| Tradename: | DICHLORPHENAMIDE |
| Applicant: | Rising |
| Ingredient: | dichlorphenamide |
| Patents: | 0 |
Pharmacology for NDA: 218783
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
Medical Subject Heading (MeSH) Categories for 218783
Suppliers and Packaging for NDA: 218783
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DICHLORPHENAMIDE | dichlorphenamide | TABLET;ORAL | 218783 | ANDA | Rising Pharma Holdings, Inc. | 16571-242 | 16571-242-01 | 100 TABLET in 1 BOTTLE (16571-242-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Nov 18, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
